Definium Therapeutics, Inc. (DFTX)
NASDAQ: DFTX · Real-Time Price · USD
20.99
-0.36 (-1.69%)
At close: May 15, 2026, 4:00 PM EDT
21.05
+0.06 (0.29%)
After-hours: May 15, 2026, 7:58 PM EDT
Definium Therapeutics Analyst Ratings
Total Analysts
8
Consensus Rating
Strong Buy
Price Target
$38.38
Upside
+82.85%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Maintains $49 → $48 | Buy | Maintains | $49 → $48 | +128.68% | May 8, 2026 |
| Leerink Partners | Leerink Partners | Buy Maintains $23 → $30 | Buy | Maintains | $23 → $30 | +42.93% | Apr 22, 2026 |
| Stifel | Stifel | Strong Buy Initiates $30 | Strong Buy | Initiates | $30 | +42.93% | Apr 17, 2026 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $25 → $38 | Strong Buy | Maintains | $25 → $38 | +81.04% | Apr 16, 2026 |
| Piper Sandler | Piper Sandler | Buy Initiates $49 | Buy | Initiates | $49 | +133.44% | Apr 10, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $55 → $70 | Strong Buy | Maintains | $55 → $70 | +233.49% | Mar 2, 2026 |
| Wolfe Research | Wolfe Research | Buy Initiates $25 | Buy | Initiates | $25 | +19.10% | Feb 24, 2026 |
| Jefferies | Jefferies | Strong Buy Initiates $30 | Strong Buy | Initiates | $30 | +42.93% | Jan 30, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $20 → $36 | Buy | Maintains | $20 → $36 | +71.51% | Jan 23, 2026 |